Prognostic alternative splicing and multi-omics characteristics reveal FTCD is a potential target of hepatocellular carcinoma
This study offers a prognostic prediction model for HCC patient risk stratification, identifying the FTCD gene as a crucial prognostic marker and therapeutic target. This highlights FTCD's potential impact on HCC clinical diagnosis and treatment strategies.
Authors
- Wenxing Li (ORCID: https://orcid.org/0000-0001-9984-8439)
- Mengyi Sun (ORCID: https://orcid.org/0009-0001-6232-1614)
- Yanli Zhang (ORCID: https://orcid.org/0000-0001-9661-3730)
- Lisheng Zhang (ORCID: https://orcid.org/0000-0002-3093-1856)
Institutions
- Huazhong Agricultural University (CN)
- Heze Medical College (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1007/s12672-024-01201-y
- Citations
- 3
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.70